{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:22:11Z","timestamp":1788459731634,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mamm Genome"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00335-026-10267-8","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:58:05Z","timestamp":1788458285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning identifies ac4C-related prognostic signature and TUBA1C as therapeutic target in COAD"],"prefix":"10.1007","volume":"37","author":[{"given":"Baizhi","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"10267_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/17501911.2025.2473308","volume":"17","author":"E B\u00e1rtov\u00e1","year":"2025","unstructured":"B\u00e1rtov\u00e1 E, Stixov\u00e1 L, Svobodov\u00e1 Kova\u0159\u00edkov\u00e1 A (2025) N4-acetylcytidine and other RNA modifications in epitranscriptome: insight into DNA repair and cancer development. Epigenomics 17:411\u2013422","journal-title":"Epigenomics"},{"key":"10267_CR4","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","volume":"398","author":"MS Carlino","year":"2021","unstructured":"Carlino MS, Larkin J, Long GV (2021) Immune checkpoint inhibitors in melanoma. Lancet 398:1002\u20131014","journal-title":"Lancet"},{"key":"10267_CR2","first-page":"198","volume":"21","author":"JC Fabregas","year":"2022","unstructured":"Fabregas JC, Ramnaraign B, George TJ (2022) Clinical updates for colon cancer care in 2022. Clin Colorectal Cancer 21:198\u2013203","journal-title":"Clin Colorectal Cancer"},{"key":"10267_CR9","doi-asserted-by":"publisher","first-page":"e2410564121","DOI":"10.1073\/pnas.2410564121","volume":"121","author":"S Gao","year":"2024","unstructured":"Gao S et al (2024) N-acetyltransferase 10 mediates cognitive dysfunction through the acetylation of GABABR1 mRNA in sepsis-associated encephalopathy. Proc Natl Acad Sci 121:e2410564121","journal-title":"Proc Natl Acad Sci"},{"key":"10267_CR12","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y et al (2021) Integrated analysis of multimodal single-cell data. Cell 184:3573\u20133587e29","journal-title":"Cell"},{"key":"10267_CR15","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P et al (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24:1550\u20131558","journal-title":"Nat Med"},{"key":"10267_CR22","doi-asserted-by":"publisher","first-page":"1695495","DOI":"10.3389\/fimmu.2025.1695495","volume":"16","author":"C Li","year":"2025","unstructured":"Li C et al (2025) The critical role of NAT10-mediated N4-acetylcytidine modification in tumor immunity. Front Immunol 16:1695495","journal-title":"Front Immunol"},{"key":"10267_CR8","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1038\/s41467-024-46458-7","volume":"15","author":"W Ma","year":"2024","unstructured":"Ma W et al (2024) N-Acetyltransferase 10 represses Uqcr11 and Uqcrb independently of ac4C modification to promote heart regeneration. Nat Commun 15:2137","journal-title":"Nat Commun"},{"key":"10267_CR20","doi-asserted-by":"publisher","first-page":"e1001453","DOI":"10.1371\/journal.pmed.1001453","volume":"10","author":"L Marisa","year":"2013","unstructured":"Marisa L et al (2013) Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLOS Med 10:e1001453","journal-title":"PLOS Med"},{"key":"10267_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM et al (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 12:453\u2013457","journal-title":"Nat Methods"},{"key":"10267_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43556-023-00139-x","volume":"4","author":"L Qiu","year":"2023","unstructured":"Qiu L, Jing Q, Li Y, Han J (2023) RNA modification: mechanisms and therapeutic targets. Mol Biomed 4:25","journal-title":"Mol Biomed"},{"key":"10267_CR17","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1161\/CIRCRESAHA.122.322244","volume":"133","author":"J Shi","year":"2023","unstructured":"Shi J et al (2023) NAT10 is involved in cardiac remodeling through ac4C-mediated transcriptomic regulation. Circ Res 133:989\u20131002","journal-title":"Circ Res"},{"key":"10267_CR21","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1053\/j.gastro.2009.11.005","volume":"138","author":"JJ Smith","year":"2010","unstructured":"Smith JJ et al (2010) Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 138:958\u2013968","journal-title":"Gastroenterology"},{"key":"10267_CR14","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci 102:15545\u201315550","journal-title":"Proc Natl Acad Sci"},{"key":"10267_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer J Clin 71:209\u2013249","journal-title":"Cancer J Clin"},{"key":"10267_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1200\/JCO.20.02088","volume":"39","author":"J Tabernero","year":"2021","unstructured":"Tabernero J et al (2021) Encorafenib plus cetuximab as a new standard of care for previously treated BRAF V600E\u2013mutant metastatic colorectal cancer: updated survival results and subgroup analyses from the BEACON study. J Clin Oncol 39:273\u2013284","journal-title":"J Clin Oncol"},{"key":"10267_CR24","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41419-025-08156-0","volume":"16","author":"L Wang","year":"2025","unstructured":"Wang L et al (2025a) Targeting the ac4C \u2018Writer\u2019 NAT10 enhances pancreatic cancer immunotherapy via dual modulation of CD8\u2009+\u2009T cells and tumor cells. Cell Death Dis 16:809","journal-title":"Cell Death Dis"},{"key":"10267_CR7","doi-asserted-by":"publisher","first-page":"e70015","DOI":"10.1002\/mco2.70015","volume":"6","author":"Q Wang","year":"2025","unstructured":"Wang Q et al (2025b) RNA N4-acetylcytidine modification and its role in health and diseases. MedComm 6:e70015","journal-title":"MedComm"},{"key":"10267_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13578-025-01504-9","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y et al (2025c) The function of NAT10-driven N4-acetylcytidine modification in cancer: novel insights and potential therapeutic targets. Cell Biosci 15:165","journal-title":"Cell Biosci"},{"key":"10267_CR11","doi-asserted-by":"publisher","first-page":"112810","DOI":"10.1016\/j.celrep.2023.112810","volume":"42","author":"W Wei","year":"2023","unstructured":"Wei W et al (2023) NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer. Cell Rep 42:112810","journal-title":"Cell Rep"},{"key":"10267_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.omtn.2023.03.023","volume":"32","author":"L Xie","year":"2023","unstructured":"Xie L et al (2023) Mechanisms of NAT10 as ac4C writer in diseases. Mol Ther Nucleic Acids 32:359\u2013368","journal-title":"Mol Ther Nucleic Acids"},{"key":"10267_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12964-023-01417-5","volume":"22","author":"S Zhang","year":"2024","unstructured":"Zhang S et al (2024) Recent advances in the potential role of RNA N4-acetylcytidine in cancer progression. Cell Commun Signal 22:49","journal-title":"Cell Commun Signal"},{"key":"10267_CR25","doi-asserted-by":"publisher","first-page":"e012254","DOI":"10.1136\/jitc-2025-012254","volume":"13","author":"Y Zhao","year":"2025","unstructured":"Zhao Y (2025) Targeting oncogenic acetyltransferase NAT10 to overcome anti-PD-1 resistance in nasopharyngeal carcinoma. J Immunother Cancer 13:e012254","journal-title":"J Immunother Cancer"},{"key":"10267_CR10","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/cac2.12363","volume":"42","author":"X Zheng","year":"2022","unstructured":"Zheng X et al (2022) N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Cancer Commun 42:1347\u20131366","journal-title":"Cancer Commun"},{"key":"10267_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12967-024-05186-8","volume":"22","author":"K Zheng","year":"2024","unstructured":"Zheng K et al (2024) Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model. J Transl Med 22:365","journal-title":"J Transl Med"}],"container-title":["Mammalian Genome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-026-10267-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00335-026-10267-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-026-10267-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:58:06Z","timestamp":1788458286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00335-026-10267-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10267"],"URL":"https:\/\/doi.org\/10.1007\/s00335-026-10267-8","relation":{},"ISSN":["0938-8990","1432-1777"],"issn-type":[{"value":"0938-8990","type":"print"},{"value":"1432-1777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"103"}}